Millions of kidney patients face the same unchanging ritual, four hours a day, three days a week hooked to a dialysis machine. A Bay Area startup believes it can streamline that experience.
They started rolling out a new dialysis machine known as the Tablo, designed to work something like a smart phone app, according to Leslie Trigg, CEO of Outset Medical in San Jose.
"So we first took a look at what dialysis machines look like today and then thought, how could we re-imagine it if we were a Google, or an Apple," says Trigg.
The answer centers on a touch screen interface, which they say allows patients to set up the dialysis session themselves in about 10 minutes. The interface includes an audio test to make sure patients can hear any alarms. It then runs through a checklist to make sure they have all the supplies they need for dialysis.
Read More: http://abc7news.com/health/new-machine-designed-to-streamline-dialysis/1408926/
Via: ABC7 News
World Economic Forum’s Technology Pioneers has announced its 2016 honorees for advances in the design, development and deployment of new technologies and innovations, including 22 US companies. Of the various health, environment and energy companies awarded the honor, Omada Health was recognized for its work in helping to combat the public health challenge of chronic disease.
Via: Omada Health
San Francisco, CA (June 27, 2016) – Omada Health, the San Francisco-based digital behavioral medicine company, was today awarded as one of the World Economic Forum’s Technology Pioneers, a selection of the world’s most innovative companies. Omada works with employers, health plans, and health systems to digitally administer intensive behavioral counseling to individuals at elevated risk of chronic conditions like type 2 diabetes and heart disease. The company generates its revenue on a pay-for-outcomes model that aligns its incentives with its organizational partners and individual participants.
"...In California and Washington state, San Francisco-based Omada Health is testing a version of Prevent, a diabetes and heart disease prevention program that's been modified for "underserved" populations – basically people on Medicaid or who are uninsured. The free program offers patients a digital scale as well as behavior counseling and education, access to a personal health coach and an online peer network.
Via: PR Newswire
The MDEAs took place June 14, in conjunction with MD&M East, happening this week in New York City
NEW YORK, June 15, 2016 /PRNewswire/ -- The Medical Design Excellence Awards (MDEA), recognizing the technological achievements of medical device manufacturers, announced the 2016 winners at a special ceremony on the evening of June 14. Produced by Medical Device and Diagnostic Industry (MD+DI), the awards ceremony honored innovation across nine categories, announcing gold, silver and bronze medal winners in each category, plus naming the best in show and revealing the readers' choice winner. The 2016 MDEA ceremony was held in conjunction with Medical Design & Manufacturing (MD&M) East, which is taking place this week at the Jacob K. Javits Convention Center in New York, NY.
Silk Road Medical Announces Updated Clinical Data on TCAR Presented at the 2016 Society for Vascular Surgery Annual Meeting
Via: PR Newsire
Presentations from the ROADSTER Study Highlight the Continued Safety, Efficacy and Durability of TransCarotid Artery Revascularization
SUNNYVALE, Calif., June 15, 2016 /PRNewswire/ -- Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, announced that the 2016 Vascular Annual Meeting of the Society for Vascular Surgery (SVS) held June 8-11 in National Harbor, MD featured six presentations on the company's ENROUTE® Transcarotid Neuroprotection and Stent System, the first and only products specifically designed and indicated for TransCarotid Artery Revascularization (TCAR).
Shire Receives FDA Breakthrough Therapy Designation for SHP621 and SHP625, Investigational Products for Rare Gastrointestinal Conditions
Update on Meritage Program:
Via: NEJM Catalyst
"....Outset Medical, based in San Jose, California, seeks to empower dialysis patients through technology.
CAMBRIDGE, Mass., May 18, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX) announced today that it has entered into an amendment to its license agreement with Tepha, Inc., a Lexington, Massachusetts based medical device company that licenses Metabolix PHA biopolymer technology for use in certain medical applications. The amendment calls for a $2.0 million lump sum payment to Metabolix. In exchange, Metabolix agreed to forgo future royalties under its existing license agreement with Tepha and to provide two additional Metabolix production strains and related intellectual property to Tepha for use in the production of Tepha's medical devices.
NEW YORK, New York, May 5, 2016 — Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving hospital-based treatment to people affected by central nervous system (CNS) related edema, today announced that the Company has launched a new website, CiraraStories.com, which will feature people afflicted by this devastating condition – patients, their families, and the medical professionals who care for them.